IP Library Granted Patent US 8,765,123
Granted Patent B1
US 8,765,123 · App. 13/609,714 · Granted Jul 1, 2014

Compositions and methods for the treatment and prevention of infections caused by

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,123
App. No.
13/609,714
Granted
Jul 1, 2014
Kind
B1
Abstract

The present invention relates to antimicrobial deoxyribonuclease-based compositions that inhibit growth and proliferation of Staphylococcus aureus bacteria. The present invention also relates to methods of administering the compositions in the treatment and prevention of S. aureus infections. The present invention also relates to methods of administering the compositions in the eradication of S. aureus nasal carriage, in order to prevent the transmission of S. aureus bacteria.

Claims (9)

1. A method for increasing sensitivity of S. aureus biofilm-embedded cells to killing, said method comprising treating the S. aureus biofilm-embedded cells with a deoxyribonuclease enzyme, wherein the antimicrobial agent or the mixture of antimicrobial agents is active against S. aureus cells followed by treatment of the deoxyribonuclease enzyme treated cells with an antimicrobial agent or mixture of antimicrobial agents.

2. The method of claim 1 wherein the deoxyribonuclease enzyme is deoxyribonuclease I.

3. The method of claim 1 wherein the deoxyribonuclease enzyme is bovine deoxyribonuclease I.

4. The method of claim 1 wherein the deoxyribonuclease enzyme is human deoxyribonuclease I.

5. The method of claim 1 wherein the antimicrobial agent is a quaternary ammonium compound.

6. The method of claim 5 wherein the quaternary ammonium compound is cetylpyridinium chloride.

7. The method of claim 1 wherein the cells are treated with the deoxyribonuclease enzyme for at least 10 minutes.

8. The method of claim 7 wherein the cells are treated with the antimicrobial agent or mixture thereof for at least 3 minutes.

9. The method of claim 1 wherein the cells are treated with at least 100 μg/ml of the deoxyribonuclease enzyme.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 27, 2021
From: RUTGERS, THE STATE UNIV OF NJ
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 056992/0542 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 13, 2014
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 033525/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2012
From: KAPLAN, JEFFREY B.
To: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 028974/0140 →